In the last 12 months, insiders at Corvus Pharmaceuticals, Inc. ($CRVS) filed 65 transactions with the SEC: 8 open-market purchases totaling $1,034,627 and 2 sales totaling $9,783,789. Net insider sentiment: net selling.
Corvus Pharmaceuticals, Inc. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- Thompson Peter A. (Director) — 31 transactions totaling $10,903,163
- ORBIMED ADVISORS LLC (Director) — 5 transactions totaling $9,783,790
- MILLER RICHARD A MD (President and CEO) — 7 transactions totaling $2,956,755
- Jones William Benton (See Remarks) — 6 transactions totaling $102,374
- van den Broek Richard (Not found) — 1 transaction totaling $0
View all SEC Filings for Corvus Pharmaceuticals, Inc. (CRVS).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 28, 2026 | Thompson Peter A. | Director | M | Common Stock | 15000 | $0.97 | 8,774,091.0000 | 82,836,369 | 0.17% | 0.02% |
| Jan. 28, 2026 | Thompson Peter A. | Director | M | Common Stock | 15000 | $0.99 | 8,759,091.0000 | 82,836,369 | 0.17% | 0.02% |
| Jan. 28, 2026 | Thompson Peter A. | Director | M | Common Stock | 30000 | $15.00 | 8,639,091.0000 | 82,836,369 | 0.35% | 0.04% |
| Jan. 28, 2026 | Thompson Peter A. | Director | M | Common Stock | 15000 | $9.70 | 8,654,091.0000 | 82,836,369 | 0.17% | 0.02% |
| Jan. 28, 2026 | Thompson Peter A. | Director | M | Common Stock | 15000 | $12.50 | 8,669,091.0000 | 82,836,369 | 0.17% | 0.02% |
| Jan. 28, 2026 | Thompson Peter A. | Director | M | Common Stock | 15000 | $3.61 | 8,684,091.0000 | 82,836,369 | 0.17% | 0.02% |
| Jan. 28, 2026 | Thompson Peter A. | Director | M | Common Stock | 15000 | $2.00 | 8,699,091.0000 | 82,836,369 | 0.17% | 0.02% |
| Jan. 28, 2026 | Thompson Peter A. | Director | M | Common Stock | 15000 | $3.27 | 8,714,091.0000 | 82,836,369 | 0.17% | 0.02% |
| Jan. 28, 2026 | Thompson Peter A. | Director | M | Common Stock | 15000 | $2.74 | 8,729,091.0000 | 82,836,369 | 0.17% | 0.02% |
| Jan. 28, 2026 | Thompson Peter A. | Director | M | Common Stock | 15000 | $2.60 | 8,744,091.0000 | 82,836,369 | 0.17% | 0.02% |
| Jan. 28, 2026 | Thompson Peter A. | Director | M | Stock Option (Right to Buy) | 15000 | $0.00 | 0.0000 | 82,836,369 | 100.00% | 0.02% |
| Jan. 28, 2026 | Thompson Peter A. | Director | M | Stock Option (Right to Buy) | 15000 | $0.00 | 0.0000 | 82,836,369 | 100.00% | 0.02% |
| Jan. 28, 2026 | Thompson Peter A. | Director | M | Stock Option (Right to Buy) | 15000 | $0.00 | 0.0000 | 82,836,369 | 100.00% | 0.02% |
| Jan. 28, 2026 | Thompson Peter A. | Director | M | Stock Option (Right to Buy) | 15000 | $0.00 | 0.0000 | 82,836,369 | 100.00% | 0.02% |
| Jan. 28, 2026 | Thompson Peter A. | Director | M | Stock Option (Right to Buy) | 15000 | $0.00 | 0.0000 | 82,836,369 | 100.00% | 0.02% |
| Jan. 28, 2026 | Thompson Peter A. | Director | M | Stock Option (Right to Buy) | 15000 | $0.00 | 0.0000 | 82,836,369 | 100.00% | 0.02% |
| Jan. 28, 2026 | Thompson Peter A. | Director | M | Stock Option (Right to Buy) | 15000 | $0.00 | 0.0000 | 82,836,369 | 100.00% | 0.02% |
| Jan. 28, 2026 | Thompson Peter A. | Director | M | Stock Option (Right to Buy) | 15000 | $0.00 | 0.0000 | 82,836,369 | 100.00% | 0.02% |
| Jan. 28, 2026 | Thompson Peter A. | Director | M | Stock Option (Right to Buy) | 15000 | $0.00 | 0.0000 | 82,836,369 | 100.00% | 0.02% |
| Jan. 28, 2026 | Thompson Peter A. | Director | M | Stock Option (Right to Buy) | 15000 | $0.00 | 0.0000 | 82,836,369 | 100.00% | 0.02% |
| Jan. 28, 2026 | Thompson Peter A. | Director | M | Stock Option (Right to Buy) | 15000 | $0.00 | 0.0000 | 82,836,369 | 100.00% | 0.02% |
| Jan. 28, 2026 | Thompson Peter A. | Director | M | Stock Option (Right to Buy) | 15000 | $0.00 | 0.0000 | 82,836,369 | 100.00% | 0.02% |
| Jan. 28, 2026 | Thompson Peter A. | Director | M | Stock Option (Right to Buy) | 30000 | $0.00 | 0.0000 | 82,836,369 | 100.00% | 0.04% |
| Jan. 28, 2026 | Thompson Peter A. | Director | M | Common Stock | 15000 | $2.12 | 8,819,091.0000 | 82,836,369 | 0.17% | 0.02% |
| Jan. 28, 2026 | Thompson Peter A. | Director | M | Common Stock | 15000 | $1.64 | 8,804,091.0000 | 82,836,369 | 0.17% | 0.02% |
| Jan. 28, 2026 | Thompson Peter A. | Director | M | Common Stock | 15000 | $2.49 | 8,789,091.0000 | 82,836,369 | 0.17% | 0.02% |
| Dec. 4, 2025 | MILLER RICHARD A MD | President and CEO | A | Stock Option (Right to Buy) | 1000000 | $0.00 | 1,000,000.0000 | 82,836,369 | 9999.99% | 1.21% |
| Dec. 4, 2025 | LEA LEIV | Chief Financial Officer | A | Stock Option (Right to Buy) | 400000 | $0.00 | 400,000.0000 | 82,836,369 | 9999.99% | 0.48% |
| Dec. 4, 2025 | Jones William Benton | See Remarks | A | Stock Option (Right to Buy) | 400000 | $0.00 | 400,000.0000 | 82,836,369 | 9999.99% | 0.48% |
| Dec. 4, 2025 | Arcara Jeffrey | Chief Business Officer | A | Stock Option (Right to Buy) | 100000 | $0.00 | 100,000.0000 | 82,836,369 | 9999.99% | 0.12% |
| Oct. 2, 2025 | Moore David Scott | Not found | A | Stock Option (Right to Buy) | 30000 | $0.00 | 30,000.0000 | 82,836,369 | 9999.99% | 0.04% |
| June 27, 2025 | ORBIMED ADVISORS LLC | Director | S | Common Stock | 1176332 | $4.16 | 7,165,006.0000 | 75,152,514 | 14.10% | 1.57% |
| June 27, 2025 | Thompson Peter A. | Director | X | Common Warrants (right to buy) | 1397684 | $0.00 | 0.0000 | 75,152,514 | 100.00% | 1.86% |
| June 27, 2025 | ORBIMED ADVISORS LLC | Director | X | Common Warrants (right to buy) | 1397684 | $0.00 | 0.0000 | 75,152,514 | 100.00% | 1.86% |
| June 27, 2025 | Thompson Peter A. | Director | X | Common Stock | 1397684 | $3.50 | 8,341,338.0000 | 75,152,514 | 20.13% | 1.86% |
| June 27, 2025 | ORBIMED ADVISORS LLC | Director | X | Common Stock | 1397684 | $3.50 | 8,341,338.0000 | 75,152,514 | 20.13% | 1.86% |
| June 27, 2025 | Thompson Peter A. | Director | S | Common Stock | 1176332 | $4.16 | 7,165,006.0000 | 75,152,514 | 14.10% | 1.57% |
| June 12, 2025 | Morrison Scott W | Not found | A | Stock Option (Right to Buy) | 15000 | $0.00 | 15,000.0000 | 75,152,514 | 9999.99% | 0.02% |
| June 12, 2025 | Grais Linda | Not found | A | Stock Option (Right to Buy) | 15000 | $0.00 | 15,000.0000 | 75,152,514 | 9999.99% | 0.02% |
| June 12, 2025 | CLARK IAN T | Not found | A | Stock Option (Right to Buy) | 15000 | $0.00 | 15,000.0000 | 75,152,514 | 9999.99% | 0.02% |
| June 12, 2025 | Thompson Peter A. | Not found | A | Stock Option (Right to Buy) | 15000 | $0.00 | 15,000.0000 | 75,152,514 | 9999.99% | 0.02% |
| June 4, 2025 | Jones William Benton | See Remarks | M | Common Stock | 19357 | $3.50 | 173,130.0000 | 75,152,514 | 12.59% | 0.03% |
| June 4, 2025 | Jones William Benton | See Remarks | M | Warrant (Right to Buy) | 19357 | $0.00 | 0.0000 | 75,152,514 | 100.00% | 0.03% |
| May 7, 2025 | MILLER RICHARD A MD | President and CEO | M | Common Stock | 559073 | $3.50 | 2,324,810.0000 | 75,152,514 | 31.66% | 0.74% |
| May 7, 2025 | MILLER RICHARD A MD | President and CEO | M | Warrant (Right to Buy) | 559073 | $0.00 | 0.0000 | 75,152,514 | 100.00% | 0.74% |
| April 8, 2025 | van den Broek Richard | Not found | A | Stock Option (Right to Buy) | 30000 | $0.00 | 30,000.0000 | 75,152,514 | 9999.99% | 0.04% |
| Dec. 20, 2024 | LEA LEIV | Chief Financial Officer | A | Stock Option (Right to Buy) | 300000 | $0.00 | 300,000.0000 | 66,701,086 | 9999.99% | 0.45% |
| Dec. 20, 2024 | Arcara Jeffrey | Chief Business Officer | A | Stock Option (Right to Buy) | 50000 | $0.00 | 50,000.0000 | 66,701,086 | 9999.99% | 0.07% |
| Dec. 20, 2024 | Jones William Benton | See Remarks | A | Stock Option (Right to Buy) | 300000 | $0.00 | 300,000.0000 | 66,701,086 | 9999.99% | 0.45% |
| Dec. 20, 2024 | MILLER RICHARD A MD | President and CEO | A | Stock Option (Right to Buy) | 750000 | $0.00 | 750,000.0000 | 66,701,086 | 9999.99% | 1.12% |
| June 13, 2024 | Morrison Scott W | Not found | A | Stock Option (Right to Buy) | 15000 | $0.00 | 15,000.0000 | 49,038,582 | 9999.99% | 0.03% |
| June 13, 2024 | Thompson Peter A. | Not found | A | Stock Option (Right to Buy) | 15000 | $0.00 | 15,000.0000 | 49,038,582 | 9999.99% | 0.03% |
| June 13, 2024 | Gould Terry P | Not found | A | Stock Option (Right to Buy) | 15000 | $0.00 | 15,000.0000 | 49,038,582 | 9999.99% | 0.03% |
| June 13, 2024 | CLARK IAN T | Not found | A | Stock Option (Right to Buy) | 15000 | $0.00 | 15,000.0000 | 49,038,582 | 9999.99% | 0.03% |
| June 13, 2024 | Grais Linda | Not found | A | Stock Option (Right to Buy) | 15000 | $0.00 | 15,000.0000 | 49,038,582 | 9999.99% | 0.03% |
| May 10, 2024 | MILLER RICHARD A MD | President and CEO | G | Common Stock | 302016 | $0.00 | 1,765,737.0000 | 49,038,582 | 14.61% | 0.62% |
| May 6, 2024 | ORBIMED ADVISORS LLC | Director | P | Common Warrants (right to buy) | 1397684 | $0.00 | 1,397,684.0000 | 49,038,582 | 9999.99% | 2.85% |
| May 6, 2024 | Thompson Peter A. | Director | P | Pre-Funded Warrants (right to buy) | 1444085 | $1.73 | 1,444,085.0000 | 49,038,582 | 9999.99% | 2.94% |
| May 6, 2024 | Thompson Peter A. | Director | P | Common Warrants (right to buy) | 1397684 | $0.00 | 1,397,684.0000 | 49,038,582 | 9999.99% | 2.85% |
| May 6, 2024 | ORBIMED ADVISORS LLC | Director | P | Pre-Funded Warrants (right to buy) | 1444085 | $1.73 | 1,444,085.0000 | 49,038,582 | 9999.99% | 2.94% |
| May 6, 2024 | MILLER RICHARD A MD | President and CEO | P | Common Stock | 577634 | $1.73 | 2,067,753.0000 | 49,038,582 | 38.76% | 1.18% |
| May 6, 2024 | Jones William Benton | See Remarks | P | Common Stock | 20000 | $1.73 | 153,773.0000 | 49,038,582 | 14.95% | 0.04% |
| May 6, 2024 | Jones William Benton | See Remarks | P | Warrant (Right to Buy) | 19357 | $0.00 | 19,357.0000 | 49,038,582 | 9999.99% | 0.04% |
| May 6, 2024 | MILLER RICHARD A MD | President and CEO | P | Warrant (Right to Buy) | 559073 | $0.00 | 559,073.0000 | 49,038,582 | 9999.99% | 1.14% |
| Feb. 28, 2024 | Arcara Jeffrey | Chief Business Officer | A | Stock Option (Right to Buy) | 400000 | $0.00 | 400,000.0000 | 48,025,274 | 9999.99% | 0.83% |